Robot | Path | Permission |
GoogleBot | / | ✔ |
BingBot | / | ✔ |
BaiduSpider | / | ✔ |
YandexBot | / | ✔ |
User-agent: * Disallow: Sitemap: |
Title | home |
Description | ",n.parentNode.insertBefore(a,n)};if(!!document.cookie.match(/cookieConsent=true/))window.gaf(); ’,{’forceSSL’:true}); Menu Home about us pipeline news pr |
Keywords | N/A |
WebSite | kalostherapeutics.com |
Host IP | 209.17.116.160 |
Location | United States |
Site | Rank |
US$2,693,486
Last updated: 2023-05-14 02:46:42
kalostherapeutics.com has Semrush global rank of 3,929,594. kalostherapeutics.com has an estimated worth of US$ 2,693,486, based on its estimated Ads revenue. kalostherapeutics.com receives approximately 310,787 unique visitors each day. Its web server is located in United States, with IP address 209.17.116.160. According to SiteAdvisor, kalostherapeutics.com is safe to visit. |
Purchase/Sale Value | US$2,693,486 |
Daily Ads Revenue | US$2,487 |
Monthly Ads Revenue | US$74,589 |
Yearly Ads Revenue | US$895,066 |
Daily Unique Visitors | 20,720 |
Note: All traffic and earnings values are estimates. |
Host | Type | TTL | Data |
kalostherapeutics.com. | A | 600 | IP: 209.17.116.160 |
kalostherapeutics.com. | NS | 3600 | NS Record: ns23.domaincontrol.com. |
kalostherapeutics.com. | NS | 3600 | NS Record: ns24.domaincontrol.com. |
kalostherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:zoho.com ~all |
",n.parentNode.insertBefore(a,n)};if(!!document.cookie.match(/cookieConsent=true/))window.gaf(); ’,{’forceSSL’:true}); Menu Home about us pipeline news presentations contact us team scientific advisory board careers Kalos Therapeutics is devoted to treating the unmet medical needs of people and animals living with debilitating, orphan, or rare diseases by discovering and developing novel therapies. Kalos is developing a groundbreaking approach to treating cancers and related comorbidities. This revolutionary technology is based upon leveraging a natural, known mechanism to regulate cell growth. therapeutic areas oncology Kalos has successfully leveraged the natural antiproliferative activity of this family of peptides creating a new chemical entity in our patented Kalos Motif(s). This platform solidifies a never before seen anti-cancer approach which slows tumor growth and addresses severe comorbidities. Our compounds contain characteristics the body uses to control hemodynamics and |
HTTP/1.1 301 Moved Permanently Server: openresty/1.19.9.1 Date: Wed, 22 Dec 2021 15:17:05 GMT Content-Type: text/html; charset=iso-8859-1 Content-Length: 238 Connection: keep-alive Location: https://kalostherapeutics.com/ X-Webcom-Cache-Status: BYPASS HTTP/2 200 server: openresty/1.17.8.2 date: Wed, 22 Dec 2021 15:17:05 GMT content-type: text/html content-length: 26789 vary: Accept-Encoding last-modified: Tue, 27 Jul 2021 00:08:40 GMT etag: "68a5-5c80fac16204b" strict-transport-security: max-age=31536000 x-content-type-options: nosniff x-frame-options: SAMEORIGIN x-xss-protection: "1; mode=block" referrer-policy: no-referrer-when-downgrade x-webcom-cache-status: BYPASS accept-ranges: bytes |
Domain Name: KALOSTHERAPEUTICS.COM Registry Domain ID: 1158308645_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-08-03T18:12:53Z Creation Date: 2007-08-16T02:08:23Z Registry Expiry Date: 2026-09-13T11:59:59Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS23.DOMAINCONTROL.COM Name Server: NS24.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-12-25T08:37:41Z <<< |